FURIEX PHARMACEUTICALS INC's ticker is and the CUSIP is 36106P951. A total of 2 filers reported holding FURIEX PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $6,137,000 | +10.9% | 57,800 | -9.1% | 0.10% | +2.2% |
| Q1 2014 | $5,533,000 | +1634.5% | 63,600 | +736.8% | 0.09% | +1760.0% |
| Q4 2013 | $319,000 | -16.7% | 7,600 | -12.6% | 0.01% | -28.6% |
| Q3 2013 | $383,000 | +17.1% | 8,700 | -9.4% | 0.01% | -12.5% |
| Q2 2013 | $327,000 | – | 9,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 7,600 | $319,000 | 0.01% |
| Citadel Advisors | 6,700 | $281,000 | 0.00% |